Gonadorelin acetate

醋酸戈那瑞林

Report date: 2026/03/30 17:02:26

Base Information

Drug NameGonadorelin acetate
Drug Alias NameGonadorelinacetatGonadorelini acetasGonadorelino acetatasGonadoreliiniasetaattiAcetato de gonadorelina +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsAmenorrheaEndometriosisProstatic Hyperplasia +[5] 
Global Approved IndicationsEndometriosisProstatic HyperplasiaPolycystic Ovary Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1989/01/17
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma
Inactive CompaniesFerring Bv
Active IndicationsEndometriosisProstatic HyperplasiaPolycystic Ovary Syndrome
Inactive IndicationsAmenorrheaInfertility

Other Information

ATC CodeH01CA01V04CM01
Related LinksDrugBankKEGG